Engineered nanomaterial risk. Lessons learnt from completed nanotoxicology studies: potential solutions to current and future challenges

PARTICLE_RISK was one of the first multidisciplinary projects funded by the European Commission’s Framework Programme that was responsible for evaluating the implications of nanomaterial (NM) exposure on human health. This project was the basis for this review which identifies the challenges that exist within the assessment of NM risk. We have retrospectively reflected on the findings of completed nanotoxicology studies to consider what progress and advances have been made within the risk assessment of NMs, as well as discussing the direction that nanotoxicology research is taking and identifying the limitations and failings of existing research. We have reflected on what commonly encountered challenges exist and explored how these issues may be resolved. In particular, the following is discussed (i) NM selection (ii) NM physico-chemical characterisation; (iii) NM dispersion; (iv) selection of relevant doses and concentrations; (v) identification of relevant models, target sites and endpoints; (vi) development of alternatives to animal testing; and (vii) NM risk assessment. These knowledge gaps are relatively well recognised by the scientific community and recommendations as to how they may be overcome in the future are provided. It is hoped that this will help develop better defined hypothesis driven research in the future that will enable comprehensive risk assessments to be conducted for NMs. Importantly, the nanotoxicology community has responded and adapted to advances in knowledge over recent years to improve the approaches used to assess NM hazard, exposure and risk. It is vital to learn from existing information provided by ongoing or completed studies to avoid unnecessary duplication of effort, and to offer guidance on aspects of the experimental design that should be carefully considered prior to the start of a new study.

[1]  Andrew D Maynard,et al.  Exposure Assessment Approaches for Engineered Nanomaterials , 2010, Risk analysis : an official publication of the Society for Risk Analysis.

[2]  D. Warheit,et al.  Comparative pulmonary toxicity assessments of C60 water suspensions in rats: few differences in fullerene toxicity in vivo in contrast to in vitro profiles. , 2007, Nano letters.

[3]  Craig A. Poland,et al.  Zeta potential and solubility to toxic ions as mechanisms of lung inflammation caused by metal/metal oxide nanoparticles. , 2012, Toxicological sciences : an official journal of the Society of Toxicology.

[4]  H Salem,et al.  Intratracheal instillation as an exposure technique for the evaluation of respiratory tract toxicity: uses and limitations. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.

[5]  A. T. Saber,et al.  Inflammatory and genotoxic effects of nanoparticles designed for inclusion in paints and lacquers , 2012, Nanotoxicology.

[6]  P. Baron,et al.  Exposure to Carbon Nanotube Material: Assessment of Nanotube Cytotoxicity using Human Keratinocyte Cells , 2003, Journal of toxicology and environmental health. Part A.

[7]  Magnus Svartengren,et al.  No Significant Translocation of Inhaled 35-nm Carbon Particles to the Circulation in Humans , 2006, Inhalation toxicology.

[8]  Keith Guy,et al.  The impact of different nanoparticle surface chemistry and size on uptake and toxicity in a murine macrophage cell line. , 2008, Toxicology and applied pharmacology.

[9]  David E Newby,et al.  Do inhaled carbon nanoparticles translocate directly into the circulation in humans? , 2006, American journal of respiratory and critical care medicine.

[10]  Younan Xia,et al.  Gold nanostructures: a class of multifunctional materials for biomedical applications. , 2011, Chemical Society reviews.

[11]  David Brown,et al.  Investigating the relationship between nanomaterial hazard and physicochemical properties: Informing the exploitation of nanomaterials within therapeutic and diagnostic applications. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[12]  N. Jacobsen,et al.  Role of oxidative damage in toxicity of particulates , 2010, Free radical research.

[13]  Richard Owen,et al.  Strategic Approaches for the Management of Environmental Risk Uncertainties Posed by Nanomaterials , 2009 .

[14]  A. Boxall,et al.  Detection and characterization of engineered nanoparticles in food and the environment , 2008, Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment.

[15]  Antonio Nunes,et al.  Length-dependent retention of carbon nanotubes in the pleural space of mice initiates sustained inflammation and progressive fibrosis on the parietal pleura. , 2011, The American journal of pathology.

[16]  Jürgen Seitz,et al.  Size dependence of the translocation of inhaled iridium and carbon nanoparticle aggregates from the lung of rats to the blood and secondary target organs , 2009, Inhalation toxicology.

[17]  Vicki H Grassian,et al.  Commercially manufactured engineered nanomaterials for environmental and health studies: Important insights provided by independent characterization , 2010, Environmental toxicology and chemistry.

[18]  Helinor J Johnston,et al.  A review of the in vivo and in vitro toxicity of silver and gold particulates: Particle attributes and biological mechanisms responsible for the observed toxicity , 2010, Critical reviews in toxicology.

[19]  W. MacNee,et al.  Particulate air pollution and acute health effects , 1995, The Lancet.

[20]  Zissis Samaras,et al.  Hazard and Risk Assessment of a Nanoparticulate Cerium Oxide-Based Diesel Fuel Additive—A Case Study , 2008, Inhalation toxicology.

[21]  Joel G Pounds,et al.  ISDD: A computational model of particle sedimentation, diffusion and target cell dosimetry for in vitro toxicity studies , 2010, Particle and Fibre Toxicology.

[22]  Günter Oberdörster,et al.  Toxicology of ultrafine particles: in vivo studies , 2000 .

[23]  Vicki Stone,et al.  Current hypotheses on the mechanisms of toxicity of ultrafine particles. , 2003, Annali dell'Istituto superiore di sanita.

[24]  R. Aitken,et al.  Carbon nanotubes: a review of their properties in relation to pulmonary toxicology and workplace safety. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[25]  J. James,et al.  Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[26]  Vicki Stone,et al.  Toxicology of nanoparticles: A historical perspective , 2007 .

[27]  G. Oberdörster,et al.  Significance of particle parameters in the evaluation of exposure-dose-response relationships of inhaled particles , 1996 .

[28]  Helinor J Johnston,et al.  A critical review of the biological mechanisms underlying the in vivo and in vitro toxicity of carbon nanotubes: The contribution of physico-chemical characteristics , 2010, Nanotoxicology.

[29]  T. Webb,et al.  Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[30]  Manuela Semmler-Behnke,et al.  Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[31]  Kyunghee Choi,et al.  Induction of inflammatory responses and gene expression by intratracheal instillation of silver nanoparticles in mice , 2011, Archives of pharmacal research.

[32]  Gerhard Scheuch,et al.  Deposition, retention, and translocation of ultrafine particles from the central airways and lung periphery. , 2008, American journal of respiratory and critical care medicine.

[33]  Vicki Stone,et al.  Identification of the mechanisms that drive the toxicity of TiO2 particulates: the contribution of physicochemical characteristics , 2009, Particle and Fibre Toxicology.

[34]  Vicki Stone,et al.  Nano-silver – feasibility and challenges for human health risk assessment based on open literature , 2010, Nanotoxicology.

[35]  Nicklas Raun Jacobsen,et al.  Mutation spectrum in FE1‐MUTATMMouse lung epithelial cells exposed to nanoparticulate carbon black , 2011, Environmental and molecular mutagenesis.

[36]  Steffen Loft,et al.  Pulmonary exposure to carbon black nanoparticles and vascular effects , 2010, Particle and Fibre Toxicology.

[37]  Vicki Stone,et al.  Interspecies comparisons on the uptake and toxicity of silver and cerium dioxide nanoparticles , 2012, Environmental toxicology and chemistry.

[38]  W. MacNee,et al.  The pro-inflammatory effects of low-toxicity low-solubility particles, nanoparticles and fine particles, on epithelial cells in vitro: the role of surface area , 2007, Occupational and Environmental Medicine.

[39]  Pratim Biswas,et al.  Assessing the relevance of in vitro studies in nanotoxicology by examining correlations between in vitro and in vivo data. , 2012, Toxicology.

[40]  J. West,et al.  The Differential Cytotoxicity of Water-Soluble Fullerenes , 2004 .

[41]  Mark Bradley,et al.  Metal Oxide Nanoparticles Induce Unique Inflammatory Footprints in the Lung: Important Implications for Nanoparticle Testing , 2010, Environmental health perspectives.

[42]  Manuela Semmler-Behnke,et al.  Size and surface charge of gold nanoparticles determine absorption across intestinal barriers and accumulation in secondary target organs after oral administration , 2011, Nanotoxicology.

[43]  D. Dockery,et al.  Epidemiology of Particle Effects , 1999 .

[44]  Lang Tran,et al.  Evaluating the uptake and intracellular fate of polystyrene nanoparticles by primary and hepatocyte cell lines in vitro. , 2010, Toxicology and applied pharmacology.

[45]  P. Baron,et al.  Exposure to Carbon Nanotube Material: Aerosol Release During the Handling of Unrefined Single-Walled Carbon Nanotube Material , 2004, Journal of toxicology and environmental health. Part A.

[46]  Mary Gulumian,et al.  The limits of testing particle-mediated oxidative stress in vitro in predicting diverse pathologies; relevance for testing of nanoparticles , 2009, Particle and Fibre Toxicology.

[47]  Craig A. Poland,et al.  Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. , 2008, Nature nanotechnology.

[48]  Yongjun Li,et al.  Comparative study of pathological lesions induced by multiwalled carbon nanotubes in lungs of mice by intratracheal instillation and inhalation , 2007, Environmental toxicology.

[49]  Christian Micheletti,et al.  Analysis of currently available data for characterising the risk of engineered nanomaterials to the environment and human health--lessons learned from four case studies. , 2011, Environment international.

[50]  Jürgen Seitz,et al.  A generator for the production of radiolabelled ultrafine carbonaceous particles for deposition and clearance studies in the respiratory tract , 2006 .

[51]  H. Krug,et al.  Oops they did it again! Carbon nanotubes hoax scientists in viability assays. , 2006, Nano letters.

[52]  Vicki Stone,et al.  The biological mechanisms and physicochemical characteristics responsible for driving fullerene toxicity. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.

[53]  Vincent Castranova,et al.  Dispersion of single-walled carbon nanotubes by a natural lung surfactant for pulmonary in vitro and in vivo toxicity studies , 2010, Particle and Fibre Toxicology.

[54]  Nicklas Raun Jacobsen,et al.  Biodistribution of gold nanoparticles in mouse lung following intratracheal instillation , 2009, Chemistry Central journal.

[55]  David M. Brown,et al.  Proinflammogenic Effects of Low-Toxicity and Metal Nanoparticles In Vivo and In Vitro: Highlighting the Role of Particle Surface Area and Surface Reactivity , 2007, Inhalation toxicology.

[56]  David M. Brown,et al.  Measurement of reactive species production by nanoparticles prepared in biologically relevant media. , 2007, Toxicology letters.

[57]  Iseult Lynch,et al.  The evolution of the protein corona around nanoparticles: a test study. , 2011, ACS nano.

[58]  D. Weed Weight of Evidence: A Review of Concept and Methods , 2005, Risk analysis : an official publication of the Society for Risk Analysis.

[59]  Keishiro Tomoda,et al.  Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. , 2008, Colloids and surfaces. B, Biointerfaces.

[60]  Nicklas Raun Jacobsen,et al.  Increased mutant frequency by carbon black, but not quartz, in the lacZ and cII transgenes of muta™mouse lung epithelial cells , 2007, Environmental and molecular mutagenesis.

[61]  Manuela Semmler-Behnke,et al.  Biodistribution of 1.4- and 18-nm gold particles in rats. , 2008, Small.

[62]  David B Warheit,et al.  Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[63]  Karluss Thomas,et al.  Moving toward exposure and risk evaluation of nanomaterials: challenges and future directions. , 2009, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[64]  R. Scholz,et al.  Modeled environmental concentrations of engineered nanomaterials (TiO(2), ZnO, Ag, CNT, Fullerenes) for different regions. , 2009, Environmental science & technology.

[65]  Steffen Loft,et al.  Hazard identification of particulate matter on vasomotor dysfunction and progression of atherosclerosis , 2011, Critical reviews in toxicology.

[66]  Vicki Stone,et al.  Nano-TiO2 – feasibility and challenges for human health risk assessment based on open literature , 2010, Nanotoxicology.

[67]  G. Oberdorster,et al.  Significance of particle parameters in the evaluation of exposure-dose-response relationships of inhaled particles. , 1996, Inhalation toxicology.

[68]  A. Peters,et al.  Respiratory effects are associated with the number of ultrafine particles. , 1997, American journal of respiratory and critical care medicine.

[69]  G. Oberdörster,et al.  Pulmonary retention of ultrafine and fine particles in rats. , 1992, American journal of respiratory cell and molecular biology.

[70]  Hassan S. Bazzi,et al.  Differences in subcellular distribution and toxicity of green and red emitting CdTe quantum dots , 2005, Journal of Molecular Medicine.

[71]  Lang Tran,et al.  Safe handling of nanotechnology , 2006, Nature.

[72]  H. Norppa,et al.  Risk assessment of engineered nanomaterials and nanotechnologies--a review. , 2010, Toxicology.

[73]  Nicklas Raun Jacobsen,et al.  Lung inflammation and genotoxicity following pulmonary exposure to nanoparticles in ApoE-/- mice , 2009, Particle and Fibre Toxicology.

[74]  S. Bhatia,et al.  Probing the Cytotoxicity Of Semiconductor Quantum Dots. , 2004, Nano letters.

[75]  Güunter Oberdürster Toxicology of ultrafine particles: in vivo studies , 2000, Philosophical Transactions of the Royal Society of London. Series A: Mathematical, Physical and Engineering Sciences.

[76]  B. Nowack,et al.  Exposure modeling of engineered nanoparticles in the environment. , 2008, Environmental science & technology.

[77]  Kiril Hristovski,et al.  The release of nanosilver from consumer products used in the home. , 2010, Journal of environmental quality.

[78]  Petra Krystek,et al.  Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. , 2008, Biomaterials.

[79]  G. Oberdörster,et al.  Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles , 2005, Environmental health perspectives.

[80]  M. Prato,et al.  Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[81]  Peter Gehr,et al.  A three-dimensional cellular model of the human respiratory tract to study the interaction with particles. , 2005, American journal of respiratory cell and molecular biology.

[82]  Claus-Michael Lehr,et al.  An in vitro triple cell co-culture model with primary cells mimicking the human alveolar epithelial barrier. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[83]  P. Møller,et al.  Oxidative stress generated damage to DNA by gastrointestinal exposure to insoluble particles. , 2012, Current molecular medicine.

[84]  Vicki Stone,et al.  An in vitro study of the potential of carbon nanotubes and nanofibres to induce inflammatory mediators and frustrated phagocytosis , 2007 .

[85]  Joel G Pounds,et al.  Particokinetics in vitro: dosimetry considerations for in vitro nanoparticle toxicity assessments. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[86]  D. Mitchell,et al.  Special report of the Massachusetts weight‐of‐evidence workgroup A weight‐of‐evidence approach for evaluating ecological risks , 1996 .

[87]  N. Bottini,et al.  Multi-walled carbon nanotubes induce T lymphocyte apoptosis. , 2006, Toxicology letters.

[88]  Steffen Loft,et al.  Oxidatively Damaged DNA in Rats Exposed by Oral Gavage to C60 Fullerenes and Single-Walled Carbon Nanotubes , 2008, Environmental health perspectives.

[89]  Steffen Loft,et al.  Modest vasomotor dysfunction induced by low doses of C60 fullerenes in apolipoprotein E knockout mice with different degree of atherosclerosis , 2009, Particle and Fibre Toxicology.

[90]  Ron C. Hardman A Toxicologic Review of Quantum Dots: Toxicity Depends on Physicochemical and Environmental Factors , 2005, Environmental health perspectives.

[91]  Nebojsa Romcevic,et al.  Inactivation of nanocrystalline C60 cytotoxicity by gamma-irradiation. , 2006, Biomaterials.

[92]  P. Borm,et al.  Concordance Between In Vitro and In Vivo Dosimetry in the Proinflammatory Effects of Low-Toxicity, Low-Solubility Particles: The Key Role of the Proximal Alveolar Region , 2008, Inhalation toxicology.

[93]  Jo Anne Shatkin,et al.  Nanomaterials: Risks and Benefits, NATO Science for Peace and Security Series C: Environmental Security , 2009 .

[94]  P. Biswas,et al.  Concept of Assessing Nanoparticle Hazards Considering Nanoparticle Dosemetric and Chemical/Biological Response Metrics , 2010, Journal of toxicology and environmental health. Part A.

[95]  Robert Gelein,et al.  EXTRAPULMONARY TRANSLOCATION OF ULTRAFINE CARBON PARTICLES FOLLOWING WHOLE-BODY INHALATION EXPOSURE OF RATS , 2002, Journal of toxicology and environmental health. Part A.

[96]  Zissis Samaras,et al.  Hazard and risk assessment of a nanoparticulate cerium oxide-based diesel fuel additive - a case study. , 2008, Inhalation toxicology.

[97]  Nancy A Monteiro-Riviere,et al.  Fullerene-based amino acid nanoparticle interactions with human epidermal keratinocytes. , 2006, Toxicology in vitro : an international journal published in association with BIBRA.

[98]  B. Rothen‐Rutishauser,et al.  A newly developed in vitro model of the human epithelial airway barrier to study the toxic potential of nanoparticles. , 2008, ALTEX.

[99]  P. Baron,et al.  Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[100]  Sir,et al.  Nanotechnology in perspective. Risks to man and the environment , 2009 .

[101]  David B Warheit,et al.  How meaningful are the results of nanotoxicity studies in the absence of adequate material characterization? , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[102]  Vicki Stone,et al.  An in vitro liver model - assessing oxidative stress and genotoxicity following exposure of hepatocytes to a panel of engineered nanomaterials , 2012, Particle and Fibre Toxicology.

[103]  Jongheop Yi,et al.  Oxidative stress and apoptosis induced by titanium dioxide nanoparticles in cultured BEAS-2B cells. , 2008, Toxicology letters.

[104]  Junko Nakanishi,et al.  Fullerene c60: inhalation hazard assessment and derivation of a period-limited acceptable exposure level. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[105]  Paul Westerhoff,et al.  Nanoparticle silver released into water from commercially available sock fabrics. , 2008, Environmental science & technology.

[106]  W. MacNee,et al.  Short-term inflammatory responses following intratracheal instillation of fine and ultrafine carbon black in rats. , 1999, Inhalation toxicology.

[107]  Miroslav D. Dramićanin,et al.  Inactivation of nanocrystalline C60 cytotoxicity by γ-irradiation , 2006 .

[108]  P. Herckes,et al.  Detection of fullerenes (C60 and C70) in commercial cosmetics. , 2011, Environmental pollution.

[109]  Antonio Marcomini,et al.  Genotoxicity, cytotoxicity, and reactive oxygen species induced by single‐walled carbon nanotubes and C60 fullerenes in the FE1‐Muta™Mouse lung epithelial cells , 2008, Environmental and molecular mutagenesis.

[110]  C. L. Tran,et al.  Concordance Between In Vitro and In Vivo Dosimetry in the Proinflammatory Effects of Low-Toxicity, Low-Solubility Particles: The Key Role of the Proximal Alveolar Region , 2008 .

[111]  David M. Brown,et al.  Size-dependent proinflammatory effects of ultrafine polystyrene particles: a role for surface area and oxidative stress in the enhanced activity of ultrafines. , 2001, Toxicology and applied pharmacology.

[112]  Jeffery A. Steevens,et al.  Potential for Occupational Exposure to Engineered Carbon-Based Nanomaterials in Environmental Laboratory Studies , 2009, Environmental health perspectives.

[113]  M. Prato,et al.  Targeted delivery of amphotericin B to cells by using functionalized carbon nanotubes. , 2005, Angewandte Chemie.

[114]  Vicki Stone,et al.  Review of fullerene toxicity and exposure--appraisal of a human health risk assessment, based on open literature. , 2010, Regulatory toxicology and pharmacology : RTP.

[115]  Helinor J Johnston,et al.  Review of carbon nanotubes toxicity and exposure—Appraisal of human health risk assessment based on open literature , 2010, Critical reviews in toxicology.

[116]  Maria Dusinska,et al.  Nanomaterials for environmental studies: classification, reference material issues, and strategies for physico-chemical characterisation. , 2010, The Science of the total environment.

[117]  Vicki Stone,et al.  Assessing exposure, uptake and toxicity of silver and cerium dioxide nanoparticles from contaminated environments , 2009, Environmental health : a global access science source.

[118]  Lang Tran,et al.  Surface derivatization state of polystyrene latex nanoparticles determines both their potency and their mechanism of causing human platelet aggregation in vitro. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[119]  Christian Micheletti,et al.  Weight of Evidence approach for the relative hazard ranking of nanomaterials , 2011, Nanotoxicology.

[120]  Miran Kwon,et al.  Exposure assessment of workplaces manufacturing nanosized TiO2 and silver , 2011, Inhalation toxicology.